AstraZeneca Announces Approval Of Soliris In Japan For Expanded Use

(RTTNews) - AstraZeneca reported that Soliris has been approved in Japan for expanded use to include the treatment of generalised myasthenia gravis in paediatric patients who are anti-acetylcholine receptor antibody-positive and whose symptoms are difficult to control with high-d https://www.nasdaq.com/articles/astrazeneca-announces-approval-of-soliris-in-japan-for-expanded-use